Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tamar Pirtskhalava
Mayo Clinic Rochester, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cenexys, Inc. (nka Unity Biotechnology)
Other : Total IP royalties, through Mayo Clinic
Please see attached.
Targeting Cellular Senescence to Extend Healthspan
OVERALL ? PROJECT NARRATIVE Khosla/Kirkland Cellular senescence is known to drive a number of aging co-morbidities. In this proposal, we will test the Geroscience Hypothesis that targeting this fundamental aging mechanism will delay, prevent, or alleviate multiple age-related disorders, including metabolic dysfunction, skeletal fragility, vascular dysfunction and frailty. If successful, the proposed studies will set the stage for pilot studies in humans using drugs that either reduce the burden of senescent cells, or modulate their inflammatory properties, to simultaneously slow or prevent multiple age-associated diseases.
Filed on July 31, 2019.
Tell us what you know about Tamar Pirtskhalava's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Tamar Pirtskhalava”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Tamar Pirtskhalava | Mayo Clinic Rochester | Conflict of Interest | Cenexys, Inc. (nka Unity Biotechnology) | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.